Industry News Moderna Secures Contract with European Union for COVID-19 VaccinesGlobal Biodefense StaffJanuary 24, 2025
Medical Countermeasures Bolstering Pandemic Preparedness: HHS Funds Accelerated Development of H5N1 VaccineGlobal Biodefense StaffJanuary 17, 2025
Biodetection Diagnosing Difficult-to-detect Pathogens in Central Nervous System InfectionsGlobal Biodefense StaffNovember 13, 2024
FDA Removes Clinical Hold on Novavax’s Combo COVID-Flu Vaccine Medical Countermeasures November 11, 2024 …
GigaGen Wins BARDA Contract to Develop Biothreat Countermeasures Medical Countermeasures October 3, 2024 …
Acurx Announces Anthrax Susceptibility to ACX-375 Analogues Medical Countermeasures September 26, 2024 …
Thylacine Biotherapeutics Earns Top Honor in Medical Threat Reduction Challenge Medical Countermeasures July 9, 2024 …
Maxwell Biosciences Enters CRADA with USAMRIID to Test Potential Therapeutics Industry News May 8, 2024 …
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 Medical Countermeasures May 6, 2024 …
Soligenix Extends Patent Protection for Filovirus Vaccine Platform to UK and South Africa Industry News April 25, 2024 …
Chikungunya Vaccine Candidate Granted Accelerated Review by EMA Medical Countermeasures February 23, 2024 …
NIH Funds Continued Development of Maxim Bio’s At-Home Test for COVID and Flu Biodetection February 1, 2024 …
Novavax Updated Protein-Based COVID-19 Vaccine Authorized in the UK Medical Countermeasures January 24, 2024 …
First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test Biodetection December 5, 2023 …
Inflammatix Completes Development for Acute Infection and Sepsis Test System Biodetection November 15, 2023 …
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
Novavax’s Prototype COVID-19 Vaccine Nuvaxovid Receives Full Approval in Singapore Medical Countermeasures October 18, 2023 …
Molecular Diagnostic Test for Six Biothreat Pathogens Receives FDA Clearance Biodetection September 19, 2023 …
Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus Industry News August 24, 2023 …